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Supplementary Figure 1: Spatial distribution of clusters with significant atrophy overlaid on the 
ICBM 152 template in MS patients with sustained fatigue (SF) compared to never fatigued (NF) 
MS patients. Correction was made for age, sex, disease duration and Expanded Disability Status 
Scale (EDSS) score (top), and for Center for Epidemiological Studies - Depression score (CES-D) 




Supplementary Figure 2: Spatial distribution of clusters with significant atrophy overlaid on the 
ICBM 152 template in MS patients with reversible fatigue (RF) compared to never fatigued (NF) 
MS patients. Correction was made for age, sex, disease duration and Expanded Disability Status 
Scale (EDSS) score (top), and for Center for Epidemiological Studies - Depression score (CES-D) 
(bottom), as well as for medication (bottom) (orange labels = family-wise error-corrected p 
value<0.05). 
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